Inventor · disambiguated record
Douglas Covey
Also filed as: COVEY DOUGLAS · COVEY DOUGLAS F
27 granted patents·9 pending applications·530 citations·filing 1985–2023
97Inventor score
Files withUNIV WASHINGTON26COVEY DOUGLAS2COVEY DOUGLAS F2WASHINGTON UNIVERSITY ST LOUIS2UNIV FLORIDA RESARCH FOUNDATIO1
Top patents by PatentIndex Score
36 records- 0198US9765110B2Neuroactive 19-alkoxy-17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using sameUNIV WASHINGTON·Filed 2013·Granted Sep 19, 2017·43 cites·20 claims
- 0297US9630986B2Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using sameUNIV WASHINGTON·Filed 2013·Granted Apr 25, 2017·49 cites·18 claims
- 0396US8759330B2Neuroactive 13,24-cyclo-18,21-dinorcholanes and structurally related pentacylic steroidsCOVEY DOUGLAS F·Filed 2010·Granted Jun 24, 2014·41 cites·19 claims
- 0495US9156876B2Modified, hydroxy-substituted aromatic structures having cytoprotective activityCOVEY DOUGLAS F·Filed 2010·Granted Oct 13, 2015·39 cites·7 claims
- 0593US10342809B2Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using sameUNIV WASHINGTON·Filed 2017·Granted Jul 9, 2019·11 cites·16 claims
- 0693US9676812B2Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using sameUNIV WASHINGTON·Filed 2013·Granted Jun 13, 2017·15 cites·7 claims
- 0793US6844456B2Modified, hydroxy-substituted aromatic structures having cytoprotective activityUNIV WASHINGTON·Filed 2001·Granted Jan 18, 2005·44 cites·25 claims
- 0892US7781421B2Neuroactive 13, 24-cyclo-18, 21-dinorcholanes and structurally related pentacyclic steriodsUNIV WASHINGTON·Filed 2004·Granted Aug 24, 2010·48 cites·39 claims
- 0984US5776959AAnticonvulsant and anxiolytic lactam and thiolactam derivativesUNIV WASHINGTON·Filed 1995·Granted Jul 7, 1998·73 cites·49 claims
- 1083US2023190770A1Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using sameWASHINGTON UNIVERSITY ST LOUIS·Filed 2023·Application pending·0 cites
- 1181US11497754B2Neurosteroids and enantiomers thereof for the prevention and treatment of neurodegenerative conditionsCOVEY DOUGLAS·Filed 2020·Granted Nov 15, 2022·2 cites·10 claims
- 1281US4874891AOpen "D" ring hormone analogsUNIV WASHINGTON·Filed 1986·Granted Oct 17, 1989·23 cites·11 claims
- 1379US10160783B2Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptorsUNIV WASHINGTON·Filed 2016·Granted Dec 25, 2018·1 cites·11 claims
- 1478US10202413B2Neuroactive enantiomeric 15-, 16- and 17-substituted steroids as modulators for GABA type-A receptorsUNIV WASHINGTON·Filed 2014·Granted Feb 12, 2019·2 cites·16 claims
- 1578US6066666AAnticonvulsant and anxiolytic lactam and thiolactam derivativesUNIV WASHINGTON·Filed 1998·Granted May 23, 2000·52 cites·29 claims
- 1676US2021308149A1Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using sameUNIV WASHINGTON·Filed 2021·Application pending·0 cites
- 1772US6680331B2Lactam and thiolactam derivatives as anesthetic and conscious sedation agentsUNIV TEXAS·Filed 2001·Granted Jan 20, 2004·4 cites·16 claims
- 1871US5344826ATricycle steroid analogsUNIV WASHINGTON·Filed 1993·Granted Sep 6, 1994·22 cites·6 claims
- 1970US5292906ATricyclic steroid analogsUNIV WASHINGTON·Filed 1993·Granted Mar 8, 1994·19 cites·3 claims
- 2069US2020113916A1Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using sameUNIV WASHINGTON·Filed 2019·Application pending·0 cites
- 2166US5206415ATricyclic steroid analogsUNIV WASHINGTON·Filed 1991·Granted Apr 27, 1993·18 cites·10 claims
- 2263US2017232006A1Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using sameUNIV WASHINGTON·Filed 2017·Application pending·0 cites
- 2362US9562026B2Neuroactive substituted cyclopent[a]anthracenes as modulators for GABA type-A receptorsUNIV WASHINGTON·Filed 2014·Granted Feb 7, 2017·0 cites·14 claims
- 2462US9512170B2Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptorsUNIV WASHINGTON·Filed 2014·Granted Dec 6, 2016·0 cites·16 claims
- 2562US6350739B1Methods of prevention and treatment of ischemic damageUNIV FLORIDA RESARCH FOUNDATIO·Filed 1999·Granted Feb 26, 2002·17 cites·22 claims
- 2661US10160738B2Neuroactive substituted cyclopent[a]anthracenes as modulators for GABA type-A receptorsUNIV WASHINGTON·Filed 2016·Granted Dec 25, 2018·0 cites·6 claims
- 2761US9365502B2Neuroactive substituted cyclopenta[b]phenanthrenes as modulators for GABA type-A receptorsUNIV WASHINGTON·Filed 2014·Granted Jun 14, 2016·0 cites·18 claims
- 2857US2006009438A2Modified, hydroxy-substituted aromatic structures having cytoprotective activityUNIV WASHINGTON·Filed 2004·Application pending·0 cites
- 2954US4707491AAnticonvulsant γ-thiobutyrolactone derivativesUNIV WASHINGTON·Filed 1985·Granted Nov 17, 1987·7 cites·7 claims
- 3054US2016326127A1NEUROACTIVE SUBSTITUTED CYCLOPENTA[b]PHENANTHRENES AS MODULATORS FOR GABA TYPE-A RECEPTORSUNIV WASHINGTON·Filed 2016·Application pending·0 cites
- 3151US10053487B2Neuroactive 19-alkoxy-17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using sameUNIV WASHINGTON·Filed 2017·Granted Aug 21, 2018·0 cites·25 claims
- 3251US2022396597A1Nmdar inhibiting agents and gabaar potentiating agents and uses thereofWASHINGTON UNIVERSITY ST LOUIS·Filed 2020·Application pending·0 cites
- 3347US2003069217A1Methods of prevention and treatment of ischemic damageFiled 2002·Application pending·0 cites
- 3441US2002132802A1Cytoprotective polycyclic compoundsWASHINGTON UNIVERISTY·Filed 2001·Application pending·0 cites
- 3533US9388210B2Neuroactive 17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using sameCOVEY DOUGLAS·Filed 2012·Granted Jul 12, 2016·0 cites·9 claims
- 3627US5434274ABenz(epsilon)indene compoundsUNIV WASHINGTON·Filed 1994·Granted Jul 18, 1995·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Douglas Covey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →